Search clinical trials for: Sodium Enoxaparine

Total 10630 results

Biocad

Completed

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Deep Vein Thrombosis

Russian Federation
French Cardiology Society

Completed

Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome

Renal Failure | Acute Coronary Syndrome

France
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Pregnancy | Heart; Complications, Valve, Prosthesis

Turkey
V.K.V. American Hospital, Istanbul

Completed

Low Molecular Weight Heparin in Recurrent Implantation Failure

Infertility | Recurrent Implantation Failure | Fertilization in Vitro

Turkey
Chemi S.p.A.

Completed

Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.

Enoxaparin Sodium is Administered to Healthy Volunteers

United Kingdom
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Venous Thromboembolism

Brazil
Indonesia University
PT Metiska Farma

Completed

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Enoxaparin

Indonesia
Oregon Health and Science University

Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Trauma | Surgery | Deep Vein Thrombosis (DVT) | Thromboembolic Events

United States
PT Bio Farma

Recruiting

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Safety Issues | Effect of Drug

Indonesia
Venus Remedies Limited

Completed

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Healthy

India
Sanofi

Completed

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Venous Thromboembolism

France, Russian Federation, Spain, Italy, Argentina, Belgium, Brazil, Canada, Colombia, Germany, Israel, Mexico, Poland, United States, Australia, Austria, India, South Africa, United Kingdom, Tunisia
Sanofi

Completed

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)

Myocardial Infarction | Acute ST-Segment Elevation

Canada, Brazil, Poland, Romania, Russian Federation, Ukraine, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Estonia, India, Malaysia, Singapore, Slovakia, Belgium, Mexico, Uruguay, Argentina, Croatia, Austr... and more
Rovi Pharmaceuticals Laboratories
PRA Health Sciences

Completed

Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers

Healthy
GlycoMimetics Incorporated
University of Michigan

Completed

Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Healthy Volunteers

United States
Bayer

Completed

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Venous Thromboembolism

United States, Canada
Tel-Aviv Sourasky Medical Center

Unknown

Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity

Obesity

Israel
University of Oulu
University of Helsinki

Unknown

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Intracerebral Hemorrhage

Finland
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Radial Artery Occlusion

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Recruiting

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty

China
GlycoMimetics Incorporated
University of Michigan

Terminated

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Deep Venous Thrombosis

United States
Sanofi

Completed

HENOX: Enoxaparine in Hemodialysis

Hemodialysis

Thailand
Sanofi

Completed

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery (TREK)

Venous Thromboembolism

Poland, Romania, Russian Federation, Portugal, Sweden, Turkey, Bulgaria, Malaysia, Philippines, Taiwan, Mexico, Argentina, Denmark, Finland, Norway, Colombia, Chile, Thailand, Greece
Oregon Health and Science University
National Trauma Research Institute; Medical Research Foundation, Oregon

Completed

Thrombelastography Based Dosing of Enoxaparin

Thromboembolic Complications

United States
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
University of Utah
University of Michigan

Completed

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Surgery | Venous Thromboembolism | Deep Venous Thrombosis

United States
Loyola University

Withdrawn

Timing of VTE Prophylaxis in TBI

TBI (Traumatic Brain Injury) | VTE (Venous Thromboembolism)

United States
Wake Forest University Health Sciences

Terminated

Clot Dissolving Treatment for Blood Clots in the Lungs

Pulmonary Embolism

United States
Oregon Health and Science University

Terminated

Below Knee DVT Study

Deep Vein Thrombosis (DVT) | Blood Clots

United States
Lebanese American University

Completed

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Renal Impairment | Venous Thromboembolism

Lebanon
Shaare Zedek Medical Center

Completed

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

Critical Illness | Venous Thrombosis

Israel
University of Utah

Completed

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
Peking Union Medical College Hospital

Completed

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) (OPTIENOX-PCI)

Coronary Artery Disease | Percutaneous Coronary Intervention

China
Hannover Medical School

Terminated

Taxotere-Enoxaparin-(ENOXA)-Study

Non-small Cell Lung Cancer

Germany
Mashhad University of Medical Sciences

Unknown

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Esophageal Neoplasms

Iran, Islamic Republic of
Sarah Sabry Hashem

Completed

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

Mitral Valve Disease

Egypt
Assistance Publique - Hôpitaux de Paris

Recruiting

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) (OPTI-TREX)

Pediatric Kidney Transplant Recipients

France
University of Cincinnati
United States Air Force

Completed

Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients

Venous Thromboembolism | Traumatic Injury

United States
Sanofi

Completed

Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)

Arthroplasty, Replacement, Hip

Japan
University of Utah
Agency for Healthcare Research and Quality (AHRQ)

Completed

Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
Massachusetts General Hospital
Sanofi; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; North...

Withdrawn

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

United States
Assistance Publique - Hôpitaux de Paris

Suspended

Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients (Childbenox)

Cirrhosis

France
University Hospital, Brest

Terminated

Prevention of Unexplained Recurrent Abortion by Enoxaparine (PREFIX)

Alive and Viable Births

France
Shenzhen Zhongshan Urology Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Unknown

Effect of LMWH on Pregnancy Outcome in Women With Multiple Failures of IVF-ET

Infertility

China
University of Sao Paulo General Hospital

Completed

Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial

Venous Thrombosis | Deep Vein Thrombosis | Pulmonary Embolism | Perioperative/Postoperative Complications | Thrombophilia Associated With Pregnancy | Other Specified Risk Factors in Pregnancy

Brazil
University Magna Graecia

Completed

Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients

SARS CoV 2 Infection | Acute Respiratory Failure | Anticoagulants

Italy
Western University, Canada
Valeo Pharma Inc

Not yet recruiting

Prolonged Hypercoagulability Following Major Liver Resection for Malignancy (PRIORITY)

Thrombosis | Hepatic Disease | Surgery-Complications | Hypercoagulability

Canada
Wake Forest University Health Sciences

Terminated

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Surgery | Regional Anesthesia Morbidity | Anticoagulants and Bleeding Disorders

United States
Sanofi

Completed

Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)

Percutaneous Coronary Intervention
Columbia University

Completed

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 (IMPROVE)

COVID-19 | Venous Thromboses | Arterial Thrombosis

United States
Sanofi

Completed

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Acute Ischemic Stroke

Korea, Republic of, Italy, Brazil, Canada, Colombia, Israel, Mexico, Poland, Czech Republic, United States, Australia, Austria, India, South Africa, Turkey

Search clinical trials for: Sodium Enoxaparine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations